Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 2
2018 3
2019 1
2020 3
2021 2
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
From biology to personalized medicine: recent knowledge in Osteosarcoma.
Mohr A, Marques Da Costa ME, Fromigue O, Audinot B, Balde T, Droit R, Abbou S, Khneisser P, Berlanga P, Perez E, Marchais A, Gaspar N. Mohr A, et al. Eur J Med Genet. 2024 Apr 25:104941. doi: 10.1016/j.ejmg.2024.104941. Online ahead of print. Eur J Med Genet. 2024. PMID: 38677541
Pre-COVID-19 Immunity to Common Cold Human Coronaviruses Induces a Recall-Type IgG Response to SARS-CoV-2 Antigens Without Cross-Neutralisation.
Miyara M, Saichi M, Sterlin D, Anna F, Marot S, Mathian A, Atif M, Quentric P, Mohr A, Claër L, Parizot C, Dorgham K, Yssel H, Fadlallah J, Chazal T, Haroche J, Luyt CE, Mayaux J, Beurton A, Benameur N, Boutolleau D, Burrel S, de Alba S, Mudumba S, Hockett R, Gunn C, Charneau P, Calvez V, Marcelin AG, Combes A, Demoule A, Amoura Z, Gorochov G. Miyara M, et al. Among authors: mohr a. Front Immunol. 2022 Feb 11;13:790334. doi: 10.3389/fimmu.2022.790334. eCollection 2022. Front Immunol. 2022. PMID: 35222375 Free PMC article.
IgA dominates the early neutralizing antibody response to SARS-CoV-2.
Sterlin D, Mathian A, Miyara M, Mohr A, Anna F, Claër L, Quentric P, Fadlallah J, Devilliers H, Ghillani P, Gunn C, Hockett R, Mudumba S, Guihot A, Luyt CE, Mayaux J, Beurton A, Fourati S, Bruel T, Schwartz O, Lacorte JM, Yssel H, Parizot C, Dorgham K, Charneau P, Amoura Z, Gorochov G. Sterlin D, et al. Among authors: mohr a. Sci Transl Med. 2021 Jan 20;13(577):eabd2223. doi: 10.1126/scitranslmed.abd2223. Epub 2020 Dec 7. Sci Transl Med. 2021. PMID: 33288662 Free PMC article.
Metabolic Optimisation of Regulatory T Cells in Transplantation.
Atif M, Mohr A, Conti F, Scatton O, Gorochov G, Miyara M. Atif M, et al. Among authors: mohr a. Front Immunol. 2020 Sep 2;11:2005. doi: 10.3389/fimmu.2020.02005. eCollection 2020. Front Immunol. 2020. PMID: 33013855 Free PMC article. Review.
Tissue Infiltrating LTi-Like Group 3 Innate Lymphoid Cells and T Follicular Helper Cells in Graves' and Hashimoto's Thyroiditis.
Mohr A, Trésallet C, Monot N, Bauvois A, Abiven D, Atif M, Claër L, Malhotra R, Mayer G, Balderas R, Vaarala O, Deniziaut G, Brocheriou I, Buffet C, Leenhardt L, Gorochov G, Miyara M. Mohr A, et al. Front Immunol. 2020 Apr 9;11:601. doi: 10.3389/fimmu.2020.00601. eCollection 2020. Front Immunol. 2020. PMID: 32328068 Free PMC article.
The regulatory capacity of B cells directs the aggressiveness of CLL.
Mohr A, Cumin M, Bagacean C, Pochard P, Le Dantec C, Hillion S, Renaudineau Y, Berthou C, Tempescul A, Saad H, Pers JO, Bordron A, Jamin C. Mohr A, et al. Oncoimmunology. 2018 Dec 12;8(3):1554968. doi: 10.1080/2162402X.2018.1554968. eCollection 2019. Oncoimmunology. 2018. PMID: 30723588 Free PMC article.
Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy.
Bordron A, Bagacean C, Mohr A, Tempescul A, Bendaoud B, Deshayes S, Dalbies F, Buors C, Saad H, Berthou C, Pers JO, Renaudineau Y. Bordron A, et al. Among authors: mohr a. Oncotarget. 2018 Aug 3;9(60):31590-31605. doi: 10.18632/oncotarget.25657. eCollection 2018 Aug 3. Oncotarget. 2018. PMID: 30167081 Free PMC article.
Human FOXP3+ T regulatory cell heterogeneity.
Mohr A, Malhotra R, Mayer G, Gorochov G, Miyara M. Mohr A, et al. Clin Transl Immunology. 2018 Jan 30;7(1):e1005. doi: 10.1002/cti2.1005. eCollection 2018. Clin Transl Immunology. 2018. PMID: 29484183 Free PMC article. Review.
Alterations in DNA methylation/demethylation intermediates predict clinical outcome in chronic lymphocytic leukemia.
Bagacean C, Tempescul A, Le Dantec C, Bordron A, Mohr A, Saad H, Olivier V, Zdrenghea M, Cristea V, Cartron PF, Douet-Guilbert N, Berthou C, Renaudineau Y. Bagacean C, et al. Among authors: mohr a. Oncotarget. 2017 Aug 9;8(39):65699-65716. doi: 10.18632/oncotarget.20081. eCollection 2017 Sep 12. Oncotarget. 2017. PMID: 29029465 Free PMC article.
12 results